This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houang, E. T. S.
Right arrow Articles by Cheng, A. F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houang, E. T. S.
Right arrow Articles by Cheng, A. F. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2001, p. 228-234, Vol. 39, No. 1
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.1.228-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Epidemiology and Infection Control Implications of Acinetobacter spp. in Hong Kong

Elizabeth T. S. Houang,1,* Y. W. Chu,1 C. M. Leung,1 K. Y. Chu,1 J. Berlau,2 K. C. Ng,1 and A. F. B. Cheng1

Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin NT, Hong Kong SAR, People's Republic of China,1 and Department of Ophthalmology, University of Rostock, 18057 Rostock, Germany2

Received 30 March 2000/Returned for modification 12 September 2000/Accepted 17 October 2000

In a previous study, we showed that Acinetobacter genomic DNA group 3 was the most common species among blood culture isolates and was commonly found on superficial carriage sites of the healthy and the sick, which are different findings from those reported in Europe and North America. We used amplified ribosomal DNA restriction analysis and pulsed-field gel electrophoresis to study further the molecular epidemiology of acinetobacters in our region. Over a study period of 6 weeks with 136 consecutive routine clinical isolates (1.33% of all specimens), genomic DNA groups 2 (Acinetobacter baumannii), 3, and 13TU were obtained from 59 of 69 positive patients. There is a significant difference in the specimen sources of the three genomic DNA groups, with group 13TU being significantly associated with the respiratory tract (chi-square exact test, P = 0.0064). Settle plates showed a significantly heavier environmental load from the intensive care unit (ICU) than from the four surgical wards examined (22 of 70 versus 76 of 120 plates with <5 colonies; chi-square test, P < 0.0001). Genomic group 3 accounted for 6 of 12 clusters of possibly related strains among patients, between patients and the ICU environment, and in the ICU environment. Genomic groups 2 and 3 accounted for 21% of the 132 genomically identified isolates recovered from 21 of 41 local vegetables, 53 of 74 fish and meat samples, and 22 of 60 soil samples. Group 13TU was present only in patients' immediate surroundings. The role played by the environment and by human carriage should be evaluated in order to devise a cost-effective infection control program pertinent to our situation of acinetobacter endemicity.


* Corresponding author. Mailing address: Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin NT, Hong Kong SAR, People's Republic of China. Phone: (852) 2632 2304. Fax: (852) 2647 3227. E-mail: ehouang{at}cuhk.edu.hk.


Journal of Clinical Microbiology, January 2001, p. 228-234, Vol. 39, No. 1
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.1.228-234.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Gundi, V. A. K. B., Dijkshoorn, L., Burignat, S., Raoult, D., La Scola, B. (2009). Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155: 2333-2341 [Abstract] [Full Text]  
  • Karageorgopoulos, D. E., Kelesidis, T., Kelesidis, I., Falagas, M. E. (2008). Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother 62: 45-55 [Abstract] [Full Text]  
  • Munoz-Price, L. S., Weinstein, R. A. (2008). Acinetobacter Infection. NEJM 358: 1271-1281 [Full Text]  
  • Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 3471-3484 [Full Text]  
  • Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., Lindler, L., Hamilton, T., Gaddy, C., Snow, K., Pe, M., Fishbain, J., Craft, D., Deye, G., Riddell, S., Milstrey, E., Petruccelli, B., Brisse, S., Harpin, V., Schink, A., Ecker, D. J., Sampath, R., Eshoo, M. W. (2006). Identification of Acinetobacter Species and Genotyping of Acinetobacter baumannii by Multilocus PCR and Mass Spectrometry.. J. Clin. Microbiol. 44: 2921-2932 [Abstract] [Full Text]  
  • Beggs, C. B., Kerr, K. G., Snelling, A. M., Sleigh, P. A. (2006). Acinetobacter spp. and the Clinical Environment. Indoor and Built Environment 15: 19-24 [Abstract]  
  • Leung, W.-S., Chu, C.-M., Tsang, K.-Y., Lo, F.-H., Lo, K.-F., Ho, P.-L. (2006). Fulminant Community-Acquired Acinetobacter baumannii Pneumonia as a Distinct Clinical Syndrome. Chest 129: 102-109 [Abstract] [Full Text]  
  • Houang, E. T. S., Chu, Y.-W., Lo, W.-S., Chu, K.-Y., Cheng, A. F. B. (2003). Epidemiology of Rifampin ADP-Ribosyltransferase (arr-2) and Metallo-{beta}-Lactamase (blaIMP-4) Gene Cassettes in Class 1 Integrons in Acinetobacter Strains Isolated from Blood Cultures in 1997 to 2000. Antimicrob. Agents Chemother. 47: 1382-1390 [Abstract] [Full Text]  
  • Houang, E. T. S., Chu, Y. W., Chu, K. Y., Ng, K. C., Leung, C. M., Cheng, A. F. B. (2003). Significance of Genomic DNA Group Delineation in Comparative Studies of Antimicrobial Susceptibility of Acinetobacter spp.. Antimicrob. Agents Chemother. 47: 1472-1475 [Abstract] [Full Text]  
  • Anstey, N. M., Currie, B. J., Hassell, M., Palmer, D., Dwyer, B., Seifert, H. (2002). Community-Acquired Bacteremic Acinetobacter Pneumonia in Tropical Australia Is Caused by Diverse Strains of Acinetobacter baumannii, with Carriage in the Throat in At-Risk Groups. J. Clin. Microbiol. 40: 685-686 [Abstract] [Full Text]